Notice of Proposed Sale · 144
Clarivate Plc
CLVTNYSEEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- CLARIVATE PLC
- Issuer CIK
- 0001764046
- SEC file number
- 001-38911
- Phone
- 44 207 4334000
- Person for whose account securities are to be sold
- JONATHAN M COLLINS
- Relationships to issuer
- Officer
- Street
- 70 St. Mary Axe
- City
- London
- State / country code
- X0
- Postal code
- EC3A 8BE
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 82,552 | 165,351.66 | 639,904,301 | 11/03/2026 | NYSE | Morgan Stanley Smith Barney LLC Executive Financial Services |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Street
- 1 New York Plaza
- Street (continued)
- 8th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 03/01/2022 | Restricted Stock | Issuer | 70,125 | N | 03/01/2022 | Not Applicable |
| Common | 03/04/2025 | Performance Shares | Issuer | 12,427 | N | 03/04/2025 | Not Applicable |
Prior-sale reporting
- Nothing to report for the preceding three months
- Y
Remarks
The securities to be sold were acquired upon the vesting of Restricted Stock during the period of 03/01/2022 through 03/15/2026. The securities to be sold were acquired upon the vesting of Performance Shares during the period of 03/04/2025 through 02/18/2026.
Notice signature
- Notice date
- 11/03/2026
- Signed
- /s/ Jonathan Mark Collins
Company context
Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property, and Life Sciences & Healthcare. For more information, please visit clarivate.com.